Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 59 (RNA5SP59; also known as RN5S59) is a pseudogene related to 5S ribosomal RNA, annotated in NCBI Gene (Gene ID: 106480357) as a non-functional copy of the 5S rRNA gene[4]. Unlike functional 5S ribosomal RNA, which serves as a structural and functional component of the large ribosomal subunit in the ribosome[1], RNA5SP59 does not encode any functional RNA or protein product. Pseudogenes generally arise through gene duplication or retrotransposition followed by disabling mutations and do not typically possess regulatory or coding activity[2]. There is no evidence that RNA5SP59 is involved in signal transduction, cell cycle, or any canonical biological process. It is not considered a druggable or therapeutic target, nor are there known biomarkers or disease associations specific to this pseudogene. Its annotation as a "pseudogene" means it is a vestige of gene evolution rather than a functional entity. Notes on correctness: - RNA5SP59 refers specifically to a *pseudogene* of 5S rRNA and *not* to the functional ribosomal RNA molecule or any protein-coding gene. - It is not recognized as a drug or therapeutic target (e.g., receptor, enzyme, transporter). - If you need information on the actual functional ribosomal 5S RNA, refer to 5S ribosomal RNA (5S rRNA), not pseudogenes like RNA5SP59[1][4]. Summary: RNA5SP59 (RNA, 5S ribosomal pseudogene 59) is a 5S rRNA pseudogene—*not* a functional gene, receptor, or drug target. It represents a nonfunctional genomic remnant and is not enriched for biomedical relevance beyond its interest in genomics and evolutionary studies[4][2][1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 59 (RNA5SP59).